Although GLP-1 RAs is not currently used clinically to treat type 1 diabetes, multiple animal and human studies have suggested their potential benefits17, 18, such as enhancing recovery of β cells19, reducing insulin dose20, decreasing HbA1c, lowering risk of hypoglycemia21, and resisting inflammation22. Here, INS is linked to type 1 diabetes mellitus.